Skip to main content
Peng Xiao, MD, Anesthesiology, Boston, MA

PengXiaoMD

Anesthesiology Boston, MA

Instructor, Anaesthesia, Massachusetts General Hospital, Harvard Medical School

Are you Dr. Xiao?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 19 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    243 Charles St
    Boston, MA 02114
    Phone+1 617-573-3380
    Fax+1 617-573-4033

Summary

  • Dr. Peng Xiao, MD is a board certified anesthesiologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts, West Virginia, and Pennsylvania. He is affiliated with Massachusetts General Hospital, Massachusetts Eye and Ear, and Tufts Medical Center.

Education & Training

  • Sidney Kimmel Medical College at Thomas Jefferson University/TJUH
    Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Anesthesiology, 1998 - 2001
  • Icahn School of Medicine at Mount Sinai (New York Eye and Ear Infirmary at Mount Sinai)
    Icahn School of Medicine at Mount Sinai (New York Eye and Ear Infirmary at Mount Sinai)Residency, Surgery, 1997 - 1998
  • Suzhou Medical College
    Suzhou Medical CollegeClass of 1982

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2001 - 2025
  • WV State Medical License
    WV State Medical License 2001 - 2025
  • PA State Medical License
    PA State Medical License 1999 - 2001
  • American Board of Anesthesiology Anesthesiology

Publications & Presentations

PubMed

Press Mentions

  • MBZUAI Welcomes Senior Delegation from Weizmann Institute in Abu Dhabi
    MBZUAI Welcomes Senior Delegation from Weizmann Institute in Abu DhabiMay 3rd, 2021
  • G42 and ONT Co-Develop Ultra-Scalable RNA Sequencing Based Solution for COVID-19 Detection
    G42 and ONT Co-Develop Ultra-Scalable RNA Sequencing Based Solution for COVID-19 DetectionJune 11th, 2020
  • UAE’s Group 42 and UK’s Oxford Nanopore Co-Develop Ultra-Scalable Solution for COVID-19 Detection
    UAE’s Group 42 and UK’s Oxford Nanopore Co-Develop Ultra-Scalable Solution for COVID-19 DetectionJune 9th, 2020
  • Join now to see all